Trabeculectomy with mitomycin C in glaucoma associated with uveitis

Twenty-four trabeculectomies performed in 24 patients for control of uveitic galucoma were retrospectively evaluated to analyze the effect of intraoperative application of mitomycin C (MMC) on the short-term outcome of trabeculectomy for glaucoma associated with uveitis. Success rates, postoperative levels of intraocular pressure (IOP), and complications were studied. After a mean follow up of 9.87 months (range, 3 to 27 months), 18 eyes (75%) achieved an IOP of 21 mm Hg or less without antiglaucoma medications. The same IOP levels with one antiglaucoma medication was achieved in four eyes (16.6%). Statistical analysis demonstrated a significant reduction in IOP postoperatively during the period studied (P = .0001). Complications observed included exacerbation of the uveitis (12.5%), choroidal detachment (12.5%), hypotony (8.3%), postoperative shallow anterior chamber (4.2%), wound leak (4.2%), hyphema (4.2%), and macular edema (4.2%). The results of this retrospective and uncontrolled study suggest that intraoperative application of MMC may be a good option for enhancement of short-term trabeculectomy success rates in cases of uveitic glaucoma.ESCOLA PAULISTA MED,DEPT OPHTHALMOL,BR-04023 SAO PAULO,BRAZILUNIV CAPE TOWN,DEPT OPHTHALMOL,CAPE TOWN,SOUTH AFRICAESCOLA PAULISTA MED,DEPT OPHTHALMOL,BR-04023 SAO PAULO,BRAZILWeb of Scienc